ClinicalTrials.gov
public full text
Public Domain
BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer
The purpose of this study is to determine whether BP-C1 is effective in the treatment of metastatic breast cancer patients who had previously received at least three lines of chemotherapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer#1139800
- Herceptin and GM-CSF for Metastatic Breast Cancer#1058370
- Comparing the Effectiveness of Breast Cancer Screening and Diagnostic Tests among Women with Different Breast Densities—The BCSC-ADVANCE Study#1912
- Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation#833671
- Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate#853332
Record · ID 1126634
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive